Drug, Food and Supplement — Interactions With Osimertinib

Rifampicin cannot safely be combined with osimertinib without careful planning by your oncologist. It significantly reduces the amount of osimertinib that reaches your bloodstream — to the point where the cancer medicine may not work effectively. If you have active tuberculosis, your oncologist and your TB doctor need to speak to each other. Alternative TB regimens that do not carry this interaction may be possible, or the timing of the two treatments may need to be planned carefully around each other.

It depends on which epilepsy medicine you take. Carbamazepine, phenytoin, and phenobarbital all reduce osimertinib levels in a way that could reduce how well it works. If you are on one of these, tell your oncologist before starting osimertinib. Some anticonvulsants do not carry this interaction, and your neurologist may be able to advise on alternatives that do not interfere. Do not stop your epilepsy medicine on your own — that is a decision for your treating doctors together.

Grapefruit and grapefruit juice are best avoided while on osimertinib. They contain compounds that inhibit the same liver enzyme that processes the medicine, which can raise the amount in your bloodstream above the intended level and increase the risk of side effects. Because the effect is unpredictable and grapefruit is easy to avoid, your team will usually advise against it. Mosambi (sweet lime) does not carry this interaction and is fine.

Omeprazole and other proton pump inhibitors are generally less of a concern with osimertinib than with some earlier EGFR medicines. Osimertinib's absorption is less sensitive to stomach acid levels. Your team should still know what acid medicines you are taking — partly because they may point to an underlying symptom worth discussing. Include them on your medicine list at every appointment, but do not stop them without being told to.

Turmeric in cooking is fine. Turmeric in medicinal doses — capsules, concentrated extracts — and many Ayurvedic preparations are a different matter. Some plant compounds can affect the liver enzymes that process osimertinib, and this is difficult to predict product by product. The concern is not about your cultural practice — it is about making sure your team knows exactly what is in your system. Bring every supplement and preparation to your appointment and ask directly whether each one is safe to continue.

Most antibiotics can be taken alongside osimertinib, but a small number need extra care. Certain antibiotics — including some fluoroquinolones and macrolides — can affect the heart's electrical rhythm, an effect osimertinib already has to a small degree. Do not delay treating an infection because of this concern. Tell the prescribing doctor that you are taking osimertinib before they choose which antibiotic, and they can select one that avoids this overlap.

Standard vitamins at recommended daily doses — vitamin D, vitamin B12, folate — are not known to cause significant interactions with osimertinib. High-dose antioxidants, concentrated green tea extract, and products marketed for liver or kidney support are less predictable and worth discussing before you continue them. The safest approach is to bring the packet of every supplement you take to your next appointment. Your team cannot assess an interaction they do not know about.

Do not stop any medicine on your own before speaking to your oncologist. Stopping an anticonvulsant, a heart medicine, or a TB treatment suddenly can itself be dangerous. Tell your oncologist at your next appointment — or sooner by phone if you have just started osimertinib and are concerned. They may recommend a switch, a timing adjustment, or closer monitoring, depending on which medicine is involved and what it is treating.